ISPOR 13th Annual European Congress Scientific Awards Winners

By Stephen Priori, Director, ISPOR Publications

2010 ISPOR Research Excellence Awards
The recipients of the 2010 ISPOR Research Excellence Award (one for Methodology Excellence and one for Application Excellence) are selected by the Awards Committee based upon publications that have appeared in respected peer-review journals and other communication venues (e.g., books, reports) during the preceding 12 months from January 1 of the year awarded. The award selection is based upon the publication's clear description of methods, along with the appropriate and creative applications (or proposal thereof in conceptual methodology work) of techniques to answer important questions in the field of pharmacoeconomics and outcomes research. Such publications will be expected to have much impact on the field, due to their acceptance and application by others.

The 2010 recipient of the ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research is:

Mara Airoldi, MSc, Research Officer, Department of Management, London School of Economics and Political Science, London, UK, as the senior author of the research paper:

“Adjusting Life for Quality Or Disability: Stylistic Difference Or Substantial Dispute?” Health Econ 2009;18:1237–47.

A Special thanks to Rajesh Balkrishnan, PhD, MS, Chair, ISPOR Research Excellence Award in Methodological Excellence and the Research Excellence Award Committee for selecting the recipient!

 

13th Annual European Congress Research Presentation Award Recipients
The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year's European Congress, the ISPOR Awards Committee evaluated 56 podium presentations and over 1,000 poster presentations.

Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective/context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation


THE RECIPIENTS  ARE: . . .

ISPOR Best Podium Research Presentation Awards

AD3-A CONCEPTUAL FRAMEWORK THAT CAPTURES THE MULTI-DIMENSIONAL ASPECT OF ADHERENCE IN A HEALTH-ECONOMIC MODEL: AN APPLICATION IN CHRONIC NON-MALIGNANT PAIN MANAGEMENT

Treur M1, Houwing NS1, Heeg B1, Kristanto P2, Botteman M3, Vo P4, Marx S4, Lockhart E4, Van Hout B5, 1Pharmerit International, Rotterdam, Netherlands, 2AARDEX Group Ltd., Belgium, 3Pharmerit North America, LLC, Bethesda, MD, USA, 6Abbott, Abbott Park, IL, USA, 7Pharmerit Ltd, York, UK

MO4-USING AHP WEIGHTS TO FILL MISSING GAPS IN MARKOV DECISION MODELS

Steuten L, Hummel M, Wetering G, Groothuis-Oudshoorn K, Doggen C, Ijzerman M

University of Twente, Enschede, The Netherlands

EQ1-PSYCHOMETRIC COMPARISON OF EQ-5D AND EQ-5D-5L IN STUDENT POPULATION

Golicki D1, Zawodnik S1, Janssen MF2, Kiljan A1, Hermanowski T1

1Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland, 2EuroQol Group, Rotterdam, The Netherlands

ISPOR Best New Investigator Podium Presentations Award

RS4-THE INFLUENCE OF UK RISK-SHARING MODELS (PATIENT ACCESS SCHEMES) ON PAYERS IN GERMANY AND THE NETHERLANDS: A QUALITATIVE RESEARCH APPROACH

Guhl N1, Kolominsky-Rabas P2, Toumi M1

1Universite Claude Bernard Lyon 1, Lyon, France, 2Centre for Health Technology Assessment (HTA) and Public Health, University of Erlangen-Nurnberg, Erlangen, Germany

AD2-THE SOCIETAL BURDEN OF POOR PERSISTENCE TO TREATMENT OF OSTEOPOROSIS IN SWEDEN

Landfeldt E1, Lundkvist J2, Strom O1

1i3 Innovus, Stockholm, Sweden, 2Amgen, Stockholm, Sweden

MO3-THE DEVELOPMENT AND VALIDATION OF A DECISION MODEL REPRESENTING THE FULL DISEASE COURSE OF ACUTE MYELOID LEUKEMIA

Leunis A1, van Beers EH2, Löwenberg B3, Redekop WK1, Uyl-De Groot CA1
1Institute for Medical Technology Assessment, Rotterdam, The Netherlands, 2Skyline Diagnostics BV, Rotterdam, The Netherlands, 3Erasmus Medical Center, Rotterdam, The Netherlands

ISPOR Best Student Podium Research Presentations Awards

EQ3- ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS

Cruz LN1, Camey SA1, Hoffmann JF1, Brazier J2, Rowen D1, Fleck MP1, Polanczyk CA1
1Federal University of Rio Grande do Sul, Porto Alegre, Brazil, 2University of Sheffield, Sheffield, UK

BI2-MULTIPLE COHORT MODELLING OF LONG-DURATION INTERVENTIONS: QUESTIONING TIME HORIZONS AND AGGREGATION ACROSS COHORTS

O'Mahony J
Erasmus Medical Center, Rotterdam, The Netherlands

 

MO2- HERD IMMUNITY AS A RESULT IN DYNAMIC AGENT BASED EPIDEMIC MODELS 

Miksch F1, Popper N2, Zauner G2, Endel G3, Schiller-Frühwirth I3, Breitenecker F1
1Vienna University of Technology, Vienna, Austria, 2Dwh Simulation Services, Vienna, Austria, 3Main Association of Austrian Social Security Institutions, Vienna, Austria

Best Research Presentations Poster Awards

PCV90-THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS SIMVASTATIN FOR THE PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH HIGH BASELINE RISK – A SWEDISH ECONOMIC EVALUATION BASED UPON THE JUPITER TRIAL

Olsson AG1, Jensen MM2, Gandhi SK3, Smolen L4, Paulsson T5

1Linköping University Sweden, Linköping, Sweden, 2AstraZeneca, Lund, Sweden, 3AstraZeneca LP, Wilmington, DE, USA, 4Medical Decision Modeling Inc., Indianapolis, IN, USA, 5AstraZeneca Nordic MC, Södertälje, Sweden

PMS33-COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE PREVIOUS DMARD THERAPY IN MEXICO

Carlos F1, Aguirre A2, Peláez-Ballestas I3

1RAC Salud Consultores S.A. de C.V., México City, D.F., Mexico, 2R A C Salud Consultores S.A. de C.V., México City, D.F., Mexico, 3Hospital General de México, Secretaría de Salud, México City, D.F., Mexico

 

PND16-MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE IN GERMANY

Guo S1, Hernández L1, Wasiak R2, Gaudig M3

1United BioSource Corporation, Lexington, MA, USA, 2United BioSource Corporation - Europe, London, UK, 3Janssen-Cilag, Neuss, Germany

Best New Investigator Research Presentations Awards

PCN97-A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB + ANASTROZOLE COMPARED TO LAPATINIB + LETROZOLE, LETROZOLE MONOTHERAPY OR ANASTROZOLE MONOTHERAPY IN THE TREATMENT OF HER2+ / HORMONE RECEPTOR POSITIVE (HR+) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

McNamara S1, Moore L2, Ray J2

1Roche Products Limited, Welwyn Garden City, Hertfordshire, UK, 2F. Hoffmann-La Roche Ltd., Basel, Switzerland

PGI13- MODELING THE LONG TERM CONSEQUENCES OF SUPPRESSING VIRAL REPLICATION IN CHRONIC HEPATITIS B: A COST-EFFECTIVENESS ANALYSIS OF ENTECAVIR (BARACLUDEŽ) IN TURKEY 

Lescrauwaet B1, Saylan M2, Malhan S3, Öksüz E3, Korkmaz M3, Kursun E3, Eminsoy G3

1Bristol-Myers Squibb, Braine-l'Alleud, Belgium, 2Bristol-Myers Squibb, Istanbul, Turkey, 3Baskent University, Ankara, Turkey

PCV68- POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO RECLASSIFY PATIENTS WITH AN INTERMEDIATE RISK BASED ON THE FRAMINGHAM RISK SCORE INTO A LOWER OR HIGHER CATEGORY TO OPTIMIZE STATIN THERAPY 

Burgers LT, Redekop WK, Severens JL

Erasmus University Rotterdam, Rotterdam, The Netherlands

 

ISPOR Best Student Poster Research Presentations Awards

PIH65-USING A GENERALIZED ADDITIVE MODEL TO EXAMINE THE RELATIONSHIP BETWEEN BODY MASS INDEX AND HEALTH-RELATED QUALITY OF LIFE IN THE ELDERLY POPULATION – RESULTS FROM THE POPULATION-BASED GERMAN KORA-AGE STUDY

Hunger M, Thorand B, Döring A, Peters A, Schunk M, Holle R

Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany

PRS17-COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN HEALTH CARE ADMINISTRATIVE DATABASES ANALYSIS

Fornari C1, Di Stasi F2, Blasi F3, Conti S1, Mantovani LG4, Merlino L5, Cesana G1

1University of Milano - Bicocca, Monza, MB, Italy, 2Nycomed S.p.a., Milan, MI, Italy, 3University of Milan - IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda, Milan, MI, Italy, 4Federico II University of Naples, Naples, Italy, 5Regional Health Authority of Lombardy, Milan, MI, Italy

PCV12- THE IMPACT OF A CLINICAL PHARMACIST INTERVENTION ON LIPID-LOWERING IN A PRIMARY CARE SETTING

Triki N1, Shani S1, Rabinovich-Protter D2, Mossinson D2, Kokia E2, Greenberg D1

1Ben Gurion University of the Negev, Beer-Sheva, Israel, 2Maccabi Healthcare Services, Tel-Aviv, Israel

 

 

A special thanks goes to all the judges, the ISPOR Annual European Congress Research Presentation Awards Chairs as well as the ISPOR Awards Committee Chair who volunteered their time and efforts in selecting the winners.

 

ISPOR 13th ANNUAL EUROPEAN CONGRESS RESEARCH AWARDS CHAIRS:

 

Podium: Zoltan Kalo, PhD, MD, MSc, Director, Health Economics Research Unit, Eotvos Lorand University, Budapest, Hungary, and

 

Poster: Tomáš Doležal, MD, PhD, Director, Institute for Health Economics and Technology Assessment, Prague, Czech Republic

ISPOR JUDGES: Mohammad Abdollahi, Bulent Akmaz, Ibrahim Al-Abbadi, Carl Asche, Rajesh Balkrishnan, Clare Battersby, Gilles Berdeaux, Murtuza Bharmal, Imre Boncz, Johanita Burger, Donald Bushnell, Sean Candrilli, Fang Chiou, Cyrus Chowdhury, Warren Cowell, Peter Dale, Erwin De Cock, Martin Duracinsky, Silvia Evers, Laia Febrer, Frank-Ulrich Fricke, William Furlong, Brian Godman, Angela Gonzalez, Gillian Hall, Brooke Harrow, Birgit Holz, Timothy Homer, Sergio Iannazzo, Sukhvinder Johal, Ian Johnson, Ashish Joshi, Sachin Kamal-Bahl, Peter Kaskel, Angela Kempel, Victor Kiri, Kathrin Kreyenberg, Michael Lees, Nicky Liebermann, Johanna Lister, Deborah Lubeck, Anne Marciniak, Shalaka Marfatia, Steve McKenna, Nick Merchant, Debanjali Mitra, Patrick Mollon, Andre Morais, Axel Muhlbacher, Claudia Nicolay, Frederick Nida, Alexander Nozdrachev, Diego Ossa, Olaf Pirk, Robert Plisko, Jonathan Plumb, Karen Rascati, Mason Russell, Maureen Rutten, Sujit Sangiry, Sarah Schmitter, Asrul Akmal Shafie, Julian Shepelev, Joerg  Spieldenner, Kunal Srivastava, Tomas Tesar, Marco Turini, Varun Vaidya, Dave Vanness, Pepjin Vemer, Birgitta von Scheele, John Walker

 

Return to ISPOR Awards Index Page | 13th Annual European Congress Main Page